University of Arizona College of Medicine-Phoenix Obstetrics and Gynecology

Topics

• Endometrial and Cervical Cancer Treatments 194
• Ovarian cancer diagnosis and treatment 164
• Maternal and fetal healthcare 79
• Pelvic floor disorders treatments 72
• PARP inhibition in cancer therapy 53
• Cervical Cancer and HPV Research 51
• Uterine Myomas and Treatments 51
• Endometriosis Research and Treatment 44
• Maternal and Perinatal Health Interventions 41
• Preterm Birth and Chorioamnionitis 41
• Pregnancy and preeclampsia studies 40
• Assisted Reproductive Technology and Twin Pregnancy 34

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Bradley Monk

2. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.

   The New England journal of medicine · 2021 · 855 citations · Bradley Monk

3. Survival with Cemiplimab in Recurrent Cervical Cancer.

   The New England journal of medicine · 2022 · 385 citations · Bradley Monk

4. Treatment advances across the cervical cancer spectrum.

   Nature reviews. Clinical oncology · 2025 · 96 citations · Bradley Monk

5. A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 358 citations · Bradley Monk

6. First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 220 citations · Bradley Monk